Multi-modal Characterisation of Gastroenteropancreatic Neuroendocrine Tumours (GEP-NETs) Treated With Targeted Radionuclide Therapy (TRT): Prospective Interventional Multicentre National Cohort

NCT06256705 · clinicaltrials.gov ↗

NA

Phase

RECRUITING

Status

80

Enrollment

OTHER

Sponsor class

Conditions

Gastroenteropancreatic Neuroendocrine Tumor
Radiotherapy

Interventions

OTHER: Simultaneous 68Ga-DOTATOC PET-MRI

Sponsor

Assistance Publique - Hôpitaux de Paris